Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus

被引:31
作者
Calvo, B
Bilbao, JR
Urrutia, I
Eizaguirre, J
Gaztambide, S
Castaño, L
机构
[1] Hosp Cruces, Endocrinol & Diabet Res Grp, Dept Endocrinol, E-48903 Baracaldo, Spain
[2] Hosp Bidasoa, Dept Pediat, E-20280 Irun, Spain
关键词
D O I
10.1210/jc.83.3.995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomal dominant disease caused by deficiency in the antidiuretic hormone arginine vasopressin (AVP) encoded by the AVP-neurophysin II (AVP-NPII) gene on chromosome 20p13. In this study, we analyzed two families with FNDI using direct automated fluorescent, solid phase, single-stranded DNA sequencing of PCR-amplified AVP-NPII DNA. In one of the families, affected individuals presented a novel nonsense mutation in exon 3 of the gene, consisting in a G to T transition at nucleotide 2101, which produces a stop signal in codon 82 (Glu) Of NPII. The premature termination eliminates part of the C-terminal domain of NPII, including a cysteine residue in position 85, which could be involved in the correct folding of the prohormone. In the second family, a G279A substitution at position -1 of the signal peptide was observed in all affected individuals. This missense mutation, which replaces Ala with Thr, is frequent among FNDI patients and is thought to reduce the efficiency of cleavage by signal peptidases.
引用
收藏
页码:995 / 997
页数:3
相关论文
共 27 条
  • [11] DETECTION OF A NOVEL ARGININE-VASOPRESSIN DEFECT BY DIDEOXY FINGERPRINTING
    KRISHNAMANI, MRS
    PHILLIPS, JA
    COPELAND, KC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (03) : 596 - 598
  • [12] NUCLEOTIDE-SEQUENCE OF CLONED CDNA-ENCODING BOVINE ARGININE VASOPRESSIN - NEUROPHYSIN-II PRECURSOR
    LAND, H
    SCHUTZ, G
    SCHMALE, H
    RICHTER, D
    [J]. NATURE, 1982, 295 (5847) : 299 - 303
  • [13] FAMILIAL NEUROHYPOPHYSEAL DIABETES-INSIPIDUS ASSOCIATED WITH A SIGNAL PEPTIDE MUTATION
    MCLEOD, JF
    KOVACS, L
    GASKILL, MB
    RITTIG, S
    BRADLEY, GS
    ROBERTSON, GL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (03) : A599 - G599
  • [14] PENDER CB, 1953, PEDIATRICS, V11, P246
  • [15] Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus
    Repaske, DR
    Summar, ML
    Krishnamani, MRS
    Gultekin, EK
    Arriazu, MC
    Roubicek, ME
    Blanco, M
    Isaac, GB
    Phillips, JA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) : 2328 - 2334
  • [16] MOLECULAR ANALYSIS OF AUTOSOMAL DOMINANT NEUROHYPOPHYSEAL DIABETES-INSIPIDUS
    REPASKE, DR
    PHILLIPS, JA
    KIRBY, LT
    TZE, WJ
    DERCOLE, AJ
    BATTEY, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (03) : 752 - 757
  • [18] CHROMOSOMAL ASSIGNMENT OF HUMAN SEQUENCES ENCODING ARGININE VASOPRESSIN NEUROPHYSIN-II AND GROWTH-HORMONE RELEASING-FACTOR
    RIDDELL, DC
    MALLONEE, R
    PHILLIPS, JA
    PARKS, JS
    SEXTON, LA
    HAMERTON, JL
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1985, 11 (02) : 189 - 195
  • [19] Rittig S, 1996, AM J HUM GENET, V58, P107
  • [20] A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: Cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus
    Rutishauser, J
    BoniSchnetzler, M
    Boni, J
    Wichmann, W
    Huisman, T
    Vallotton, MB
    Froesch, ER
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (01) : 192 - 198